Mitsubishi UFJ Trust & Banking Corp Buys 549 Shares of Axon Enterprise, Inc $AXON

Mitsubishi UFJ Trust & Banking Corp raised its stake in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 1.8% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 31,290 shares of the biotechnology company’s stock after purchasing an additional 549 shares during the period. Mitsubishi UFJ Trust & Banking Corp’s holdings in Axon Enterprise were worth $25,906,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also modified their holdings of the company. Vanguard Group Inc. raised its holdings in Axon Enterprise by 2.2% during the 1st quarter. Vanguard Group Inc. now owns 8,632,008 shares of the biotechnology company’s stock valued at $4,540,005,000 after buying an additional 185,571 shares during the period. Alliancebernstein L.P. boosted its stake in Axon Enterprise by 15.9% during the first quarter. Alliancebernstein L.P. now owns 1,284,935 shares of the biotechnology company’s stock worth $675,812,000 after buying an additional 175,890 shares during the period. Westfield Capital Management Co. LP increased its position in Axon Enterprise by 29.8% during the first quarter. Westfield Capital Management Co. LP now owns 927,801 shares of the biotechnology company’s stock valued at $487,977,000 after acquiring an additional 212,931 shares during the last quarter. Northern Trust Corp raised its stake in shares of Axon Enterprise by 1.2% in the first quarter. Northern Trust Corp now owns 725,720 shares of the biotechnology company’s stock valued at $381,692,000 after acquiring an additional 8,794 shares during the period. Finally, Jennison Associates LLC lifted its holdings in shares of Axon Enterprise by 23,203.7% in the 1st quarter. Jennison Associates LLC now owns 614,053 shares of the biotechnology company’s stock worth $322,961,000 after acquiring an additional 611,418 shares during the last quarter. 79.08% of the stock is owned by institutional investors.

Axon Enterprise Stock Down 0.5%

Shares of NASDAQ AXON opened at $554.37 on Friday. Axon Enterprise, Inc has a 52-week low of $469.24 and a 52-week high of $885.91. The firm has a market capitalization of $43.75 billion, a price-to-earnings ratio of 136.88, a PEG ratio of 29.49 and a beta of 1.45. The stock has a 50 day moving average price of $702.88 and a 200 day moving average price of $734.15. The company has a debt-to-equity ratio of 0.63, a quick ratio of 2.71 and a current ratio of 2.95.

Axon Enterprise (NASDAQ:AXON) last released its quarterly earnings data on Wednesday, November 5th. The biotechnology company reported $1.17 EPS for the quarter, missing the consensus estimate of $1.63 by ($0.46). The firm had revenue of $710.64 million for the quarter, compared to analysts’ expectations of $704.83 million. Axon Enterprise had a return on equity of 6.80% and a net margin of 13.64%.The company’s revenue for the quarter was up 30.6% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.45 earnings per share. Sell-side analysts expect that Axon Enterprise, Inc will post 5.8 earnings per share for the current year.

Insider Transactions at Axon Enterprise

In other Axon Enterprise news, CEO Patrick W. Smith sold 10,000 shares of the stock in a transaction dated Monday, September 8th. The shares were sold at an average price of $743.64, for a total transaction of $7,436,400.00. Following the transaction, the chief executive officer directly owned 3,043,982 shares in the company, valued at $2,263,626,774.48. This represents a 0.33% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Brittany Bagley sold 5,000 shares of the business’s stock in a transaction dated Monday, September 29th. The shares were sold at an average price of $713.88, for a total transaction of $3,569,400.00. Following the completion of the sale, the chief financial officer owned 93,592 shares of the company’s stock, valued at approximately $66,813,456.96. This represents a 5.07% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders have sold 38,622 shares of company stock worth $26,439,364. Corporate insiders own 5.70% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on AXON shares. Zacks Research downgraded shares of Axon Enterprise from a “strong-buy” rating to a “hold” rating in a report on Tuesday, September 2nd. JMP Securities restated a “market outperform” rating and set a $825.00 target price on shares of Axon Enterprise in a research report on Monday, September 29th. Piper Sandler reduced their price target on Axon Enterprise from $893.00 to $753.00 and set an “overweight” rating on the stock in a report on Wednesday, November 5th. UBS Group dropped their price objective on Axon Enterprise from $840.00 to $610.00 and set a “neutral” rating for the company in a report on Wednesday, November 5th. Finally, Northland Securities set a $800.00 price objective on Axon Enterprise in a research report on Tuesday, August 5th. Fourteen analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $810.71.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.